Johnson & Johnson agreed to buy several over-the-counter medicines sold in Russia from J.B. Chemicals & Pharmaceuticals for about $260 million as it expands into emerging markets.
The brands included in the acquisition are Rinza, Russia's leading multi-symptom cough and cold brand, and Doktor Mom, Russia's No. 2 cough brand, Johnson & Johnson said Monday. Russia is the world's eighth-largest over-the-counter market, Johnson & Johnson said.
The deal is expected to close by the middle of the year.